Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aqua Bio Technology Share Issue/Capital Change 2019

Aug 28, 2019

3535_iss_2019-08-28_f74afc5f-60dd-43a6-a273-42c2fb6b2853.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Aqua Bio Technology Asa – Exercise of Warrants

Aqua Bio Technology Asa – Exercise of Warrants

Reference is made to the stock exchange notice of Aqua Bio Technology ASA ("ABT"

or the "Company") published on 14 February 2019 and on 28 June 2019, regarding

independent subscription rights issued by the Company ("Warrants").

Each Warrant gives the holder a right to subscribe for one (1) share in the

Company at a subscription price of NOK 2.50 per share.  The exercise period for

the Warrants commenced on 30 June 2019 and expires on 1 September 2019. Warrants

that are not exercised within the end of 1 September 2019 will lapse

automatically without compensation to the holder.

ABT have received confirmation for an exercise of 3,200,000 warrants for gross

proceeds of NOK 8 million.

* Member of the Board Roger Hofseth (through Finnvik Eiendom AS) has exercised

1,500,000 Warrants for an amount of NOK 3,750,000;

* Member of the Board Jan Pettersson (through Initia AB and Swelandia

International AB) has exercised 1,200,000 Warrants for an amount of NOK

3,000,000;

* Chairman of the Board Edvard Cock (through Blixen Invest AS) has exercised

500,000 Warrants for an amount of NOK 1,250,000

If no other Warrants are exercised before the end of the exercise period Roger

Hofseth will own 3,687,000 shares (24.6%), Jan Pettersson will own 3,720,000

shares (24.9%) and Edvard Cock will own 1,000,000 shares (6.7%).

For further information, please contact Espen Kvale, acting CEO, telephone

+47 916 28 092 or [email protected]

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skin care products. ABT's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skin care products developed by partners towards consumers and

professional users. Aqua Bio Technology is listed on the Axess market of the

Oslo Stock Exchange.

This information is subject to the disclosure requirements pursuant to section

5-12 of the Norwegian Securities Trading Act.